AKT1 and gastric cancer: Moreover, treatment with LY294002 or paclitaxel reduced cell viability and induced apoptosis compared with the hypoxic GC cells, suggesting that PI3K/Akt-targeted therapy with paclitaxel is more efficacious for treating GC with activated PI3K/Akt signaling.